[China Pharmas, Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 September 23, 2011 VIA EDGAR Ms. Tabatha Akins Staff Accountant Division ofrporation Finance 100 F Street, NE Re: China Pharmas, Form 10-K for the fiscal year ended December 31, 2010 Filed March 3, 2011 and Amended March 17, 2011]
[SCHEDULE 14A x o Check the appropriate box: o o x o o Biostar Pharmaceuticals, _____________________________________ Payment of Filing Fee (Check the appropriate box): x o (1) Title of each class of securities to which transaction applies:______________________________________ (2)gregate number of securities to which transaction applies:______________________________________ (3) (4) Proposed maximumgregate value of transaction: ______________________________________]
[SCHEDULE 14A x o Check the appropriate box: o o x o o Biostar Pharmaceuticals, _____________________________________ Payment of Filing Fee (Check the appropriate box): x o (1) Title of each class of securities to which transaction applies:______________________________________ (2)gregate number of securities to which transaction applies:______________________________________ (3) (4) Proposed maximumgregate value of transaction: ______________________________________]
[Explanatory Note This Form 10-Q/A should be read innjunction with the original Form 10-Q, whichntinues toeak of thete of the Form 10-Q. Exceptecifically notedove, this Form 10-Q/A does not modify or update disclosures in the original Form 10-Q. Accordingly, this Form 10-Q/A does not reflect events occurring after the filing of the Form 10-Q or]
[FORM 10-Q/A Amendment No.1 (Mark One) x June 30, 2011 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including]
[FORM 10-Q/A Amendment No.1 (Mark One) x June 30, 2011 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including]
